UNSPSC 51351617: Methylestrenolone

This classification denotes a progesterone congener with the molecular formula C19H28O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 743F1Z557A, chemically known as 17alpha-Methyl-19-nortestosterone but generally known as Methylestrenolone, which bears US NIH Compound Identifier 5284597. European Medicines Agency schedules Methylestrenolone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14667MIG. SMILES: CC12CCC3C(C1CCC2(C)O)CCC4=CC(=O)CCC34.

UNSPSC 51351617 Methylestrenolone is a Commodity code covering procurement of this synthetic anabolic steroid, which state and local governments buy in limited, specialized contexts—primarily for veterinary pharmaceutical applications and, in rare cases, for medical research or controlled therapeutic use under strict regulatory oversight. The code applies to purchase of the active pharmaceutical ingredient or finished pharmaceutical product formulations containing methylestrenolone.

State and local procurement activity under this code is minimal to absent. The source provides no recent contract opportunities, issuing bodies, geographic activity, or representative solicitations against this Commodity code. Methylestrenolone is a controlled substance under federal law, and state and local government demand for it outside of specialized veterinary or research settings is negligible. Pursuit of opportunities under this code is not advisable based on current market signals.